HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pfeifhofer, C. Articles by Baier, G. Search for Related Content PubMed PubMed Citation Articles by Pfeifhofer, C. Articles by Baier, G.

Defective IgG2a/2b Class Switching in PKC^–/– Mice¹

Christa Pfeifhofer^*, Thomas Gruber^*, Thomas Letschka^*, Nikolaus Thuille^*, Christina Lutz-Nicoladoni^*, Natascha Hermann-Kleiter¹, Uschi Braun, Michael Leitges^2, and Gottfried Baier^2,3,*

^* Department for Medical Genetics, Molecular and Clinical Pharmacology, Medical University, Innsbruck, Austria; and Department of Experimental Endocrinology, Medical University, Hanover, Germany

Using model tumor T cell lines, protein kinase C (PKC) has been implicated in IL-2 cytokine promoter activation in response to Ag receptor stimulation. In this study, for the first time, PKC null mutant mice are analyzed and display normal T and B lymphocyte development. Peripheral CD3⁺ PKC-deficient T cells show unimpaired activation-induced IL-2 cytokine secretion, surface expression of CD25, CD44, and CD69, as well as transactivation of the critical transcription factors NF-AT, NF-B, AP-1, and STAT5 in vitro. Nevertheless, CD3/CD28 Ab- and MHC alloantigen-induced T cell proliferation and IFN- production are severely impaired in PKC^–/– CD3⁺ T cells. Consistently, PKC-deficient CD3⁺ T cells from OVA-immunized PKC-deficient mice exhibit markedly reduced recall proliferation to OVA in in vitro cultures. In vivo, PKC-deficient mice give diminished OVA-specific IgG2a and IgG2b responses following OVA immunization experiments. In contrast, OVA-specific IgM and IgG1 responses and splenic PKC^–/– B cell proliferation are unimpaired. Our genetic data, thus, define PKC as the physiological and nonredundant PKC isotype in signaling pathways that are necessary for T cell-dependent IFN- production and IgG2a/2b Ab responses.

This article has been cited by other articles:

				J.-P. Evenou, J. Wagner, G. Zenke, V. Brinkmann, K. Wagner, J. Kovarik, K. A. Welzenbach, G. Weitz-Schmidt, C. Guntermann, H. Towbin, et al. The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 792 - 801. [Abstract] [Full Text] [PDF]

				T. Letschka, V. Kollmann, C. Pfeifhofer-Obermair, C. Lutz-Nicoladoni, G. J. Obermair, F. Fresser, M. Leitges, N. Hermann-Kleiter, S. Kaminski, and G. Baier PKC-{theta} selectively controls the adhesion-stimulating molecule Rap1 Blood, December 1, 2008; 112(12): 4617 - 4627. [Abstract] [Full Text] [PDF]